UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported 6/24/2005)
Med Gen Inc.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 000-29171 65-0703559
- --------------------------- ---------------- -------------------
(State or other Jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
7284 West Palmetto Park Road, Suite #207, Boca Raton, FL 33433
- -------------------------------------------------------------------------
(Address of principal executive offices)
561-750-1100
- -------------------------------------------------------------------------
(Issuer's telephone number)
Not Applicable
- -------------------------------------------------------------------------
(Former name or former address, if changed since last report)
All Correspondence to:
Paul B Kravitz CEO
C/O Med Gen Inc.
7284 West Palmetto Park Road
Suite #207
Boca Raton, FL 33433
Item 8.01 Other Events.
On June 23rd, 2005 the Company received the proxy certification
from the Transfer Agent and the results were as follows:
For: 15,695,218
Against: 351,452
Abstain: 10,000
The Amendment to increase the authorized shares from 50,000,000 to
250,000,000 Passed by majority vote. The Company has taken all necessary
steps to file the appropriate documents in Nevada, and to amend its
certificate of incorporation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Med Gen Inc.
Date: June 24, 2005
/s/Paul B. Kravitz
----------------------------------
Paul B. Kravitz,
Chairman & Chief Executive Officer